Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations of Paxlovid, currently the most prescribed oral treatment. As with its ...

This development comes at a time when pharmaceutical firms are discontinuing discovery efforts in next-generation COVID-19 treatments.

The White House on Friday morning launched a new website championing the theory that the coronavirus that causes Covid-19 was ...

Numerous treatment options for COVID-19 have been approved by the U.S. Food and Drug Administration over the last four years, including antiviral drugs and monoclonal antibodies that suppress an ...

Gilead has outlined its plans to develop and ramp up production of its remdesivir COVID-19 drug, with CEO Daniel O’Day pledging to ensure it is affordable after phase 3 results showed it ...

which has produced “promising” evidence in the clinic through a compassionate use programme suggesting that this class of drugs may relieve injury to the lungs caused by the coronavirus.

Researchers have shown a new drug compound can prevent long COVID symptoms in mice – a landmark finding that could lead to a future treatment for the debilitating condition.

The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on track to be cleared until Tuesday afternoon, a person familiar with the ...

Numerous treatment options for COVID-19 have been approved by the U.S. Food and Drug Administration over the last four years, including antiviral drugs and monoclonal antibodies that suppress an ...

The compounds identified by Frantz have chemical properties similar to hydroxychloroquine and chloroquine, two immunosuppressive drugs that were previously used to treat and prevent malaria, that have ...

A new study has found that most COVID-19 treatments approved in the United States are safe and not linked to serious side ...

The agency is sitting on a decision to grant full approval for Novavax’s shot, days after top vaccine regulator pushed out.